NPI: 1124407044 · RAPID CITY, SD 57701 · Urgent Care Clinic/Center · NPI assigned 05/26/2015
Authorized official PIERCE, JOHN controls 18+ related entities in our dataset. Read more
| Authorized Official | PIERCE, JOHN (PRESIDENT MONUMENT HEALTH) |
| NPI Enumeration Date | 05/26/2015 |
Other providers sharing the same authorized official: PIERCE, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,556 | $57K |
| 2019 | 3,611 | $86K |
| 2020 | 2,471 | $53K |
| 2021 | 4,234 | $131K |
| 2022 | 7,820 | $216K |
| 2023 | 8,560 | $307K |
| 2024 | 10,006 | $442K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,954 | 12,350 | $541K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,440 | 2,136 | $157K |
| 0240U | 986 | 960 | $112K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,717 | 1,504 | $104K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 688 | 662 | $78K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,489 | 1,341 | $46K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,020 | 965 | $43K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,226 | 1,014 | $43K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,573 | 705 | $22K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 925 | 814 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,586 | 1,327 | $19K |
| 0352U | 214 | 126 | $16K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 159 | 143 | $15K |
| 36415 | Collection of venous blood by venipuncture | 2,660 | 2,219 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,744 | 1,494 | $12K |
| 80053 | Comprehensive metabolic panel | 1,143 | 1,006 | $10K |
| 71046 | Radiologic examination, chest; 2 views | 592 | 516 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,015 | 821 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 170 | 168 | $9K |
| 81003 | 1,747 | 1,473 | $3K | |
| 81025 | 432 | 362 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 62 | 46 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 311 | 265 | $1K |
| 87420 | 99 | 80 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 62 | 46 | $925.00 |
| 74019 | 16 | 14 | $262.21 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 17 | 17 | $185.43 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 28 | 24 | $137.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 139 | 112 | $101.24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 44 | 27 | $30.34 |